Oric Pharmaceuticals, Inc. ORIC Current ratio

Current ratio at other companies

PfizerPFE

1.2×0.0×

ArriVent BioPharma, Inc.AVBP

14×-0.4×

CG OncologyCGON

22.2×+0.1×

Olema Pharmaceuticals, Inc.OLMA

10.9×-4.3×

Stoke Therapeutics, Inc.STOK

9×+0.6×

NTH

Neonc Technologies HoldingsNTHI

0.2×+0.1×

FAQ

What is Oric Pharmaceuticals, Inc.'s current ratio?

Oric Pharmaceuticals, Inc. (ORIC) reported current ratio of 16.3× in Q1 2026.

How has Oric Pharmaceuticals, Inc.'s current ratio changed year-over-year?

Oric Pharmaceuticals, Inc.'s current ratio increased by 36.1% year-over-year, from 12× to 16.3×.

What is the long-term trend for Oric Pharmaceuticals, Inc.'s current ratio?

Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s current ratio has grown at a -15.6% compound annual growth rate (CAGR), from 33× to 14.1×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.